DaVita schedules Q2 2026 investor conference call
The call will discuss results on August 4 at 5 p.m. ET, with webcast available.
See the latest news and media coverage for DaVita. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of kidney care and dialysis services
davita.comLast updated
In short: DaVita reported strong 2026 financial growth, expanded AI-driven kidney care platforms, and secured strategic home-health partnerships.
The call will discuss results on August 4 at 5 p.m. ET, with webcast available.
The kidney care leader focuses on patient outcomes, teammate opportunities, and environmental resilience, building on prior five-year goals.
Revenues reached $3.416 billion, operating income $482 million, and diluted EPS $2.87. The company repurchased 3 million shares.
The initiative promotes integrated cardiovascular, kidney, and metabolic care using evidence-based tools across 150 sites to improve outcomes and reduce costs. DaVita invests in AI and multidisciplinary teams.
DaVita rose 1.3% to an all-time high 239.46 Tuesday. Over the last two quarters DaVita reported...
DAVITA INC has an Investment Rating of HOLD; a target price of $249.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety...
In the most recent trading session, DaVita HealthCare (DVA) closed at $217.04, indicating a +1.72% shift from the previous trading day.
In recent months, DaVita reported stronger-than-expected first quarter 2026 results, lifted its earnings outlook, and ...
Track DaVita and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to DaVita and other trending companies.